IBF Term Project Initial Project Writeup:
T/T 1st Slot (50265), Group 1
Group Members:
 Ahsan Kamran (21736)
 Muhammad Anas (21679)
 Syed Ashar Ahmed (22554)
 Asfandyar Baber (22529)
Abbott Laboratories (Pakistan)
Abbott Laboratories (Pakistan) Limited is an American MNC operating in many countries,
including Pakistan. Operating in the Healthcare/Pharmaceutical industry, it is the secondlargest pharmaceutical company in Pakistan with a market share of 5.9%. It generated total
sales of PKR 30.16 billion in 2019, with a simultaneous Gross Profit Margin of 28.3%.
Abbott produces medicinal products in areas such as pediatrics, respiration, hospital care,
general health, etc. Their product sold in the most volume is Brufen, while other highselling products including Arinac, Serc, and Ensure. Consequently, their customers range
from the general public to clinics to hospitals; for the latter, Aga Khan Hospital, South City
Hospital, and Ziauddin Hospital are amongst their major clients. Being in the medicinal
industry, Abbott has several competitors, with the likes of Getz Pharma, SAMI
Pharmaceuticals, and Searle Co acting as local competitors, and GlaxoSmithKline (British
MNC) and Sanofi (French MNC) acting as foreign competitors. According to Abbott’s own
PESTLE analysis, several factors are affecting its demand/supply, for better and worse,
including:
 Political uncertainty
 Economic issues such as labor costs, interest rates, inflation, economic growth, etc.
 Social compliance (or non-compliance) with CSR
 Technological obsolescence
 Legal compliance issues with various laws
 Environmental concerns/CSR